A clinical formulation indicated for Erectile Dysfunction. This treatment supports the relaxation of penile blood vessels to facilitate increased flow and performance readiness.
A long-acting PDE5 inhibitor developed to support erectile function and intended to alleviate urinary symptoms of an enlarged prostate to manage daily health.
Mechanism of Action
It works by inhibiting the PDE5 enzyme, which allows blood vessels to relax and increases blood flow to the penis and prostate area.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
Up to 36 hours
Contraindications
Concurrent use of nitrates, Severe heart or kidney disease, Unstable angina, Allergy to tadalafil
Information for Tadarise is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
